Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Sotera Health Company before investing.

In this article, we go over a few key elements for understanding Sotera Health Company’s stock price such as:

• Sotera Health Company’s current stock price and volume
• Why Sotera Health Company’s stock price changed recently
• Upgrades and downgrades for SHC from analysts
• SHC’s stock price momentum as measured by its relative strength

About Sotera Health Company (SHC)

Before we jump into Sotera Health Company’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Want to learn more about Sotera Health Company’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Sotera Health Company.

Sotera Health Company’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Sotera Health Company’s stock price was $17.860.

Sotera Health Company is up 0.06% from its previous closing price of $17.850.

During the last market session, Sotera Health Company’s stock traded between $17.510 and $17.910. Currently, there are approximately 284.89 million shares outstanding for Sotera Health Company.

Sotera Health Company’s price-earnings (P/E) ratio is currently at 43.8, which is high compared to the Life Sciences Tools & Services industry median of 43.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Sotera Health Company Stock Price History

Sotera Health Company’s (SHC) price is currently up 0.62% so far this month.

During the month of July, Sotera Health Company’s stock price has reached a high of $18.550 and a low of $16.830.

Over the last year, Sotera Health Company has hit prices as high as $19.850 and as low as $11.000. Year to date, Sotera Health Company’s stock is up 1.25%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Sotera Health Company Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 2 analysts who downgraded Sotera Health Company’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Sotera Health Company’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Sotera Health Company’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Sotera Health Company’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Sotera Health Company (SHC) by visiting AAII Stock Evaluator.

Relative Price Strength of Sotera Health Company

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Sotera Health Company has a weighted four-quarter relative price strength of 9.15%, which translates to a Momentum Score of 81 and is considered to be Very Strong.

Want to learn more about how Sotera Health Company is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Sotera Health Company Stock Price: Bottom Line

As of July 31, 2026, Sotera Health Company’s stock price is $17.860, which is up 0.06% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Sotera Health Company stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.